Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 14:11 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | FL | 80 beds | Grade C | EBITDA uplift $3.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 103044 | MARTIN, FL | 80 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 80-bed suburban community hospital in MARTIN, FL with $47.4M in net patient revenue and a 29.4% operating margin. The hospital serves a payer mix of 72.9% Medicare, 0.1% Medicaid, and 27.0% commercial.

Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 29.4% to 36.7% (+736bps).

Net Revenue HCRIS$47.4M
Current EBITDA COMPUTED$13.9M
Operating Margin COMPUTED29.4%
Occupancy HCRIS96.3%
Revenue / Bed COMPUTED$592K
Net-to-Gross HCRIS76.2%
Distress Probability ML44.3%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
122
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 29.4% places it above the state median. Among 122 size-comparable peers (40-160 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 122 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)FL80$47.4M29.4%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
HOMESTEAD HOSPITALFL159$270.4M-11.1%
NEMOURS CHILDRENS HOSPITALFL130$268.7M-10.2%
DOCTORS HOSPITALFL130$250.0M0.9%
ADVENTHEALTH ZEPHYRHILLSFL149$207.1M-0.8%
ADVENTHEALTH DELANDFL142$197.1M2.8%
ASCENSION SACRED HEART BAYFL126$192.1M-6.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$994K+210bp18mo
Cost to Collect4.5%2.5%$947K+200bp12mo
Denial Rate Reduction12.0%6.5%$938K+198bp12mo
A/R Days Reduction5200.0%3800.0%$576K+122bp9mo
Clean Claim Rate88.0%96.0%$30K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$994K
Cost to Collect
$947K
Denial Rate Reduction
$938K
A/R Days Reduction
$576K
Clean Claim Rate
$30K
Total EBITDA Uplift$3.5M
Current EBITDA$13.9M
+ RCM Uplift+$3.5M
Pro Forma EBITDA$17.4M
Current Margin29.4%
Pro Forma Margin36.7%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$21.4M$126.6M5.92x42.7%
Base (11x exit)10.0x11.0x$21.4M$146.2M6.83x46.9%
Bull Case9.0x11.0x$19.3M$164.6M8.55x53.6%
Bull (12x exit)9.0x12.0x$19.3M$185.3M9.62x57.3%
Bear Case11.0x10.0x$23.5M$102.2M4.34x34.1%
Bear (11x exit)11.0x11.0x$23.5M$120.1M5.10x38.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 72.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 122 hospitals with 40-160 beds
  • Same-state prioritization (n=123)
  • Comp margins: P25=-10.2% / P50=2.8% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.